GlassScriptPhysician profile
Reagan Simpson
NPI 1730564402
$2,033.98
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $24.93 · 2020: $238 · 2021: $559 · 2022: $445 · 2023: $740 · 2024: $27.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $767.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $766.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $469.66 | 2021-2023 | Rybelsus, Ozempic |
| Abbvie INC. | $380.73 | 2021-2023 | Vraylar, Ubrelvy, Qulipta |
| Pfizer INC. | $247.38 | 2020-2024 | |
| Lilly USA, LLC | $237.19 | 2020-2023 | Mounjaro, Trulicity |
| Astrazeneca Pharmaceuticals LP | $154.38 | 2020-2023 | Farxiga, Brilinta |
| Amarin Pharma, INC. | $133.21 | 2019-2021 | |
| Amgen INC. | $113.20 | 2021-2023 | Otezla, Repatha |
| Horizon Therapeutics Plc | $75.64 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $46.94 | 2022 | |
| Novartis Pharmaceuticals Corporation | $30.78 | 2023 | |
| Janssen Pharmaceuticals, INC | $27.35 | 2021 | |
| Medicure Pharma INC. | $19.01 | 2022 | |
| Almatica Pharma LLC | $15.52 | 2021 | |
| Dexcom, INC. | $15.45 | 2023 | Dexcom G6 Transmitter |
| Mylan Specialty L.P. | $15.44 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $14.97 | 2023 | Freestyle Libre 2 |
| Allergan, INC. | $14.14 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.67 | 2021 | |
| Merck Sharp & Dohme LLC | $11.32 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Reagan Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.